 |
Allogeneic Epstein-Barr virus specific cytotoxic T lymphocytes |
|---|---|
| Trade Name | |
| Orphan Indication | Post-transplant lymphoproliferative disorder |
| EU Market Approval | EU |
| EU Designation Date | 2016-03-21 00:00:00 |
| Sponsor | Atara Biotherapeutics Ireland Limited |
| |
Allogeneic Epstein-Barr virus specific cytotoxic T lymphocytes |
|---|---|
| Trade Name | |
| Orphan Indication | Post-transplant lymphoproliferative disorder |
| EU Market Approval | EU |
| EU Designation Date | 2016-03-21 00:00:00 |
| Sponsor | Atara Biotherapeutics Ireland Limited |